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Here we have developed a hypoxia response element driven imaging strategy that combined the hypoxia-driven
expression of two optical reporters with different half-lives to detect temporal changes in hypoxia and hypoxia
inducible factor (HIF) activity. For this purpose, human prostate cancer PC3 cells were transfectedwith the luciferase
gene fused with an oxygen-dependent degradation domain (ODD-luc) and a variant of the enhanced green
fluorescent protein (EGFP). Both ODD-luciferase and EGFP were under the promotion of a poly-hypoxia-response
element sequence (5xHRE). The cells constitutively expressed tdTomato red fluorescent protein. For validating the
imaging strategy, cells were incubated under hypoxia (1% O2) for 48 hours and then reoxygenated. The luciferase
activity of PC3-HRE-EGFP/HRE-ODD-luc/tdtomato cells detected by bioluminescent imaging rapidly decreased after
reoxygenation, whereas EGFP levels in these cells remained stable for several hours. After in vitro validation, PC3-
HRE-EGFP/HRE-ODD-luc/tdtomato tumors were implanted subcutaneously and orthotopically in nude male mice
and imaged in vivo and ex vivo using optical imaging in proof-of-principle studies to demonstrate differences in
optical patterns between EGFP expression and bioluminescence. This novel "timer" imaging strategy of combining
the short-lived ODD-luciferase and the long-lived EGFP can provide a time frame of HRE activation in PC3 prostate
cancer cells and will be useful to understand the temporal changes in hypoxia and HIF activity during cancer
progression and following treatments including HIF targeting strategies.
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Hypoxia is frequently found in tumors and contributes to
aggressiveness, resistance to treatment, and metastatic dissemination
[1–4]. The adaptive response of cancer cells to hypoxia is mediated
through the stabilization of hypoxia inducible factors (HIFs) that
increases the transcription of several genes mediating this response by
binding to hypoxia response elements (HREs) in the promoter region
of these genes [5]. HIF is a heterodimeric basic helix-loop-helix PAS
(Per-ARNT-Sim) domain containing transcription factor that
consists of one of three oxygen-regulated α-subunits, HIF-1α,
HIF-2α, and HIF-3α, and a constitutively expressed β-subunit
(HIF-β/ARNT) [6,7]. The α-subunits are constitutively transcribed
and translated, but are regulated at the protein level by oxygen-
dependent hydroxylation of specific prolyl residues and degraded
Figure 1. Description of the "timer" strategy for HIF imaging in PC3 prostate cancer cells. (A) Under normoxia, hydroxylation of the ODD of
HIF-α triggers the degradation of this subunit. Under hypoxia, HIF-α stabilizes, and the dimer HIF-α/HIF-β binds to HRE sequences in the
5xHRE-ODD-luc and 5xHRE-EGFP constructs, resulting in the formation of long-lived EGFP and short-lived ODD-luciferase proteins. (B)
Upon reoxygenation, the ODD sequence causes a rapid degradation of the ODD-luciferase fusion protein, whereas EGFP protein levels
remain stable for longer periods. The RFP tdTomato is used as a constitutive reporter.
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(ODD) [8]. The stabilization of HIF under hypoxia and its binding
to the HRE provide a strategy to detect hypoxia by linking the HRE
to the expression of optical reporter genes. Because increased HIF
expression and stabilization can also occur under normoxia due to
factors such as epi-/genetic HIF upregulation, PI3K-mTor pathway
activation, and reactive oxygen species [9,10], such a strategy can also
be used to detect HIF activity [11]. Tumor hypoxia evolves because of
poor vascularization [9,10] but can resolve following increased
angiogenesis and reoxygenation, making it important to track the
dynamics of hypoxia and HIF activity in tumors.
Reporter genes that allow the visualization of molecular events in
cells are widely used to track cells in vitro and in vivo when
constitutively expressed [12–14]. Alternatively, these tools allow
monitoring the activity of transcription factors such as HIF when
specific promoters drive the expression of the reporter gene [15].
Among reporter genes, fluorescent proteins such as red and green
fluorescent protein (RFP and GFP) are commonly used to study gene
expression, protein trafficking, and cell localization in tissues [16]. In
bioluminescence imaging (BLI), the firefly luciferase is the most
commonly used reporter gene. In the presence of ATP and Mg++,
luciferase catalyzes the oxidation of D-luciferin to oxyluciferin. This
reaction also generates light (560 nm) [15,17]. Although the
administration of D-luciferin is required, BLI is a sensitive imaging
modality that allows monitoring cell migration, proliferation, and/or
activation of signaling pathways in vivo [15,17].
The use of a destabilized variant of the enhanced green fluorescent
protein (pd2EGFP) to characterize the relationship between hypoxia
and vascularization in a PC3 prostate cancer xenograft model has beenpreviously described [18–20]. The luciferase protein fused with
ODD, under the promotion of five copies of HRE (5xHRE-ODD-
luc), has also been previously used to monitor HIF-1 activity in
xenograft tumors using BLI [11]. Addition of an ODD sequence
strongly reduced the stability of the luciferase under normoxia,
allowing dynamic monitoring of HIF-1 activity in vivo [11].
Here we have developed an imaging strategy based on the
simultaneous HRE-driven expression of a long-lived EGFP and a
short-lived luciferase fused to ODD in prostate cancer PC3 cells.
Both reporter proteins were placed under the control of a 5xHRE
sequence (schematic shown in Figure 1, A and B). PC3 cells also
constitutively expressed tdTomato RFP to allow cell tracking
(schematic shown in Figure 1B). This "timer" strategy can provide
information on the temporal evolution of HIF activity and hypoxia in
tumors. Because orthotopic tumor models better mimic clinical
tumors compared with subcutaneous xenografts [21–23], we also
performed in vivo and ex vivo imaging of the dual HIF reporter
system (EGFP/ODD-luciferase) in PC3 tumors implanted subcuta-
neously and orthotopically in the prostate and observed patterns of
EGFP and BLI colocalization as well as regions with low overlap in
subcutaneous and orthotopic tumors and metastatic nodules.Material and Methods
Generation of the 5xHRE-ODD-luc Construct with a
Puromycin Selection Marker
To construct the plasmid encoding the luciferase gene fused to
ODD under the control of a poly-HRE sequence (5xHRE) with a
puromycin resistance cassette, the 5xHRE-ODD-luc (firefly luciferase
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(kindly provided by Dr. H. Harada) was digested with restriction
enzymes KpnI and XbaI (NEB, Ipswich, MA) and subcloned
between KpnI and EcoRI of a pGL4.21 [luc2P/Puro] (Promega,
Madison, WI) vector.
Generation of the PC3-HRE-EGFP/HRE-ODD-luc/tdTomato
Cell Line
Human prostate cancer PC3 cells and PC3 cells expressing the
enhanced green fluorescent protein variant pd2EGFP under the
promotion of a 5xHRE sequence (PC3-HRE-EGFP) were transfected
with the 5xHRE-ODD-luc construct (PC3-HRE-ODD-luc and
PC3-HRE-EGFP/HRE-ODD-luc) using jetPRIME reagent (Polyplus
transfection Inc., New York, NY) following themanufacturer’s protocol.
Transfected cells were next selected using 1 μg/ml of puromycin.
PC3-HRE-EGFP/HRE-ODD-luc cells constitutively expressing the
bright RFP tdTomato (PC3-HRE-EGFP/HRE-ODD-luc/tdTomato)
were generated by lentiviral infection with the pRRL-Δluc-tdTomato
plasmid. This plasmid was cotransfected in 293T cells with VSVG and
ΔR8.2 plasmids to produce high-titer lentiviral particles.
Cell Culture and Hypoxia Treatment
PC3 cells were grown in RPMI medium with L-glutamine
supplemented with 10% (v/v) fetal bovine serum. PC3-HRE-EGFP
cells were supplemented with 400 μg/ml of G418, PC3-HRE-ODD-
luc cells were supplemented with 1 μg/ml of puromycin, and
PC3-HRE-EGFP/HRE-ODD-luc/tdTomato cells were supplemented
with both 400 μg/ml of G418 and 1 μg/ml of puromycin.
Hypoxic treatment of cells was performed either by placing the
plates in a modular incubator chamber (Billups-Rothenberg, Del
Mar, CA), flushed at 2 psi for 3 minutes with a gas mixture of 1%
O2/5% CO2, and N2 for the balance, or by treating cells with
200 μM of CoCl2 for 24 hours to chemically mimic hypoxia.
Fluorescence Imaging
For fluorescence quantification experiments, PC3-HRE-EGFP
and PC3-HRE-EGFP/HRE-ODD-luc/tdTomato cells were seeded
at low density in six-well plates and allowed to grow for 2 weeks. The
resulting cell colonies were incubated at 1% O2 for 48 hours and
imaged after reoxygenation using a Nikon inverted microscope
equipped with a Nikon Coolpix digital camera (Nikon Instruments,
Inc., Melville, NY) at 20× magnification. Exposure times were kept
constant during time-lapse imaging experiments. For EGFP imaging,
background signal was subtracted using the rolling ball algorithm
from ImageJ software (NIH), and brightness was adjusted. All image
corrections were kept similar within experiments. For fluorescence
quantification, regions of interest were manually drawn for each cell,
and fluorescence quantification was performed using the following
formula [24]:
Cell fluorescence intensity
¼ sum of cell pixel intensities– mean background intensity cell areað Þ
Luciferase Activity Measurements
PC3-HRE-ODD-luc and PC3-HRE-EGFP/HRE-ODD-luc/
tdTomato cells grown at 80% to 90% confluence in 6-well plates
were washed with PBS and lysed in Cell Culture Lysis Reagent
(Promega) at various time points after hypoxia treatments. The
luciferase activity was measured in cell lysates using Luciferase AssaySystems (Promega) following manufacturer’s instructions. Luciferase
activity measurements were performed using a Victor 3V plate reader
(Perkin Elmer, Waltham, MA).
Western Blots
Whole cell extracts from 80% to 90% confluent 10-mm dishes
were prepared in radioimmune precipitation buffer, fractionated by
SDS-PAGE, transferred to a nitrocellulose membrane, and subjected
to immunoblot assays using a monoclonal anti-EGFP, mouse
antibody (dilution 1:2000, BD Biosciences, San Jose, CA), an
anti-HIF-1α antibody (dilution 1:1000, Novus Biologicals, Denver,
CO), and a monoclonal anti-actin mouse antibody (dilution
1:50000, Sigma, St. Louis, MO). Horseradish peroxidase–conjugated
secondary antibody against either mouse or rabbit IgG was used at
1:2000 dilutions. The signal was visualized using ECL Plus reagents
(Thermo Scientific, Rockford, IL). For experiments involving
cycloheximide (CHX, Sigma), an inhibitor of protein synthesis, cell
extracts from 105 cells were loaded per lane. Otherwise, protein
quantification was performed before sample loading. CHX toxicity
was assessed using the trypan blue exclusion test.
Animal Studies
All experimental animal protocols were approved by the
Institutional Animal Care and Use Committee of the Johns Hopkins
University School of Medicine. Animal studies were performed on
adult nude male mice inoculated subcutaneously with 2 × 106
million cancer cells. For orthotopic implantation, a 1-mm3 piece of
tumor tissue was microsurgically sutured into the prostate gland
through a small incision as previously described [20]. Tumor pieces
were obtained from a subcutaneous tumor and carefully dissected
under a fluorescence microscope to remove hypoxic and necrotic
tissue. Subcutaneous and orthotopic tumor volumes were approxi-
mately 400 to 500 mm3 at the time of imaging.
Optical Imaging
Optical imaging was performed using a Xenogen IVIS Spectrum
system (Caliper Life Sciences, Hopkinton, MA). EGFP was detected
using an excitation light of 500 nm and an emission filter set at
540 nm. tdTomato was detected using an excitation light of 570 nm
and an emission filter set at 620 nm. For in vitro bioluminescence
experiments, D-luciferin (150 μg/ml) (Promega) was added to samples
before imaging. For in vivo BLI experiments, D-luciferin dissolved in
PBS was injected intraperitoneally (3 mg/mouse) 15 minutes before
imaging. Exposure times were kept constant within experiments. End
point fluorescence and bioluminescence imaging of fresh 2-mm–thick
tumor slices prepared with a tissue slicer was performed with the
Xenogen system or using a 1× objective on a fluorescence microscope
(Nikon Ltd., Melville, NY). Fluorescence and bioluminescence
quantification was performed on manually drawn regions of interest
using the Living Image software (Perkin Elmer). The average radiant
efficiency [(photons/s per cm2 per sr)/(μW/cm2)] was determined for
fluorescence images, and the average radiance (photons/s per cm2 per sr)
was measured for bioluminescence images.
Statistical Analyses
All results are represented as means ± SEM. Comparisons
between groups were performed using Student’s t test when two
groups were compared. One-way analysis of variance followed by
Tukey's multiple comparison tests was used when more than two
groups were compared. P b .05 was considered to be statistically
Figure 2. Time-lapse imaging of EGFP and tdTomato fluorescence in control (−CHX) and CHX-treated (+CHX) PC3-HRE-GFP/
HRE-ODD-luc/tdTomato cells after 48 hours at 1% O2. The upper panel shows representative images of the evolution of EGFP and
tdTomato fluorescence in control and CHX-treated cell colonies after reoxygenation. The lower panel shows the quantification of EGFP
(☐) and tdTomato (•) fluorescence in the corresponding control or CHX-treated cell colonies (100 μg/ml). EGFP and tdTomato intensities
were normalized to values at time zero. Data are expressed as mean ± SEM.
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protein half-lives were determined using the GraphPad Prism
software (La Jolla, CA).Results
EGFP Is More Stable than ODD-luc in PC3-HRE-EGFP/
HRE-ODD-luc/tdTomato Cells Following Reoxygenation
To characterize the stability of EGFP, PC3-HRE-EGFP/
HRE-ODD-luc/tdTomato cells were incubated under hypoxia
(48 hours at 1% O2) and then reoxygenated. As shown in Figure 2,
bright green fluorescence was observed in cell colonies immediately
after the hypoxia was released. The green fluorescence remained
stable for 4 hours and then progressively started to decrease to
undetectable levels within 24 hours after reoxygenation (Figure 2).
The same experiment was repeated with cells treated with CHX
after hypoxia to inhibit de novo protein synthesis. With CHX
(100 μg/ml), EGFP fluorescence intensity was detected 4 hours
after reoxygenation but was barely detectable 8 hours after
reoxygenation (Figure 2). The EGFP degradation half-life was
approximately 15 hours without CHX treatment and approximately
83 minutes in CHX-treated cells. In both control and CHX-treated
cells, tdTomato fluorescence intensity was initially dim and
progressively increased to become stable 4 hours after reoxygenation
(Figure 2). The decrease in tdTomato fluorescence was observedwhen cells were incubated at 1% O2 but not when treated with
200 μM of CoCl2 for 24 hours (Figure S1). To confirm microscopy
results, the stability of EGFP after reoxygenation was also characterized
in immunoblots. As shown in Figure 3A, EGFP protein levels remained
stable for 8 hours in cells without CHX after reoxygenation. On the
other hand, EGFP protein levels decreased progressively in
CHX-treated cells but remained detectable up to 6 hours after
reoxygenation. CHX was found to be nontoxic in PC3 cells, and cell
numbers remained stable after CHX addition (Figure S2).
We next examined the stability of the luciferase protein fused with
ODD in PC3-HRE-EGFP/HRE-ODD-luc/tdTomato cells after a
48-hour incubation at 1% O2. Figure 3B shows that the luciferase
activity quickly decreased after reoxygenation. After 4 hours of
reoxygenation, the luciferase activity was 24.85 ± 4.81% of its
original value in control cells and 8.80 ± 0.8% in CHX-treated cells
(Figure 3B). The ODD-luciferase half-life was approximately
34 minutes in control cells without CHX treatment and approxi-
mately 11 minutes in CHX-treated cells.
The stability of EGFP and ODD-luc after reoxygenation was also
characterized in PC3 cells carrying either the 5xHRE-EGFP construct
(PC3-HRE-EGFP) or the 5xHRE-ODD-luc construct
(PC3-HRE-ODD-luc). Briefly, the stability of both reporters was
found to be similar in PC3-HRE-EGFP and PC3-HRE-ODD-luc
cells compared with PC3-HRE-EGFP/HRE-ODD-luc/tdTomato
cells (Figure S3).
Figure 3. Evolution of EGFP and ODD-luciferase expression in
control (−CHX) and CHX-treated (+CHX) PC3-HRE-GFP/HRE-ODD-
luc/tdTomato cells after 48 hours at 1% O2. (A) Representative
Western blot showing the decrease in EGFP proteins following
reoxygenation in control and CHX-treated cells (100 μg/ml). (B)
Evolution of luciferase activity in control (•) and CHX-treated cells
(○, 100 μg/ml) after reoxygenation (n = 3). Data are expressed as
mean ± SEM.
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PC3-HRE-GFP/HRE-ODD-luc/tdTomato Cells Indicate a
Reoxygenation Process
To validate the use of the long-lived EGFP and short-lived
ODD-luciferase for discriminating hypoxia, normoxia, and reoxy-
genation in PC3 cells, PC3-HRE-EGFP/HRE-ODD-luc/tdTomato
cells were incubated under hypoxia for 4, 8, 24, and 48 hours and
then reoxygenated. Protein levels of HIF-1α, EGFP, and the
luciferase activity of these cells were measured just after reoxygenation
or 4 hours after hypoxia release. As shown in Figure 4A, 4 hours of
hypoxia was sufficient to stabilize HIF-1α. However, EGFP
expression could only be detected after 8 hours of hypoxia, and a
strong EFGP induction was observed after a 24-hour incubation at
1% O2 (Figure 4, A and B). Whatever the duration of hypoxia,
EGFP protein levels and EGFP fluorescence did not decrease 4 hours
after reoxygenation (Figure 4, A and B). In agreement with previous
results (Figure 2), the fluorescence of tdTomato was found to be
reduced just after 24- and 48-hour incubation at 1% O2 but not
4 hours after reoxygenation (Figure 4B).
A 4-hour incubation of PC3-HRE-EGFP/HRE-ODD-luc/
tdTomato cells at 1% O2 was sufficient to induce a 1.76 ±
0.17-fold increase in luciferase activity (Figure 5). However, the
luciferase activity of PC3-HRE-EGFP/HRE-ODD-luc/tdTomato
cells incubated at 1% O2 for 4 hours and reoxygenated for 4 hourswas not statistically different from the hypoxia group (Figure 5).
When cells were submitted to hypoxia for 8, 24, or 48 hours, a strong
increase in the luciferase activity was measured in comparison with
normoxic cells (Figure 5). A statistically significant drop in the
luciferase activity was observed in cells reoxygenated for 4 hours after
8-, 24-, and 48-hour incubation at 1% O2 in comparison with
hypoxic groups (Figure 5).
Optical Imaging Allows HIF-1 Imaging in PC3-HRE-GFP/
HRE-ODD-luc/tdTomato Cells
Using optical imaging, we next aimed to image simultaneously
EGFP, tdTomato, and bioluminescence produced by
PC3-HRE-EGFP/HRE-ODD-luc/tdTomato cells. For these exper-
iments, microtubes containing CoCl2-treated (200 μM for 24 hours)
or normoxic cell pellets (3×106 cells/tube) were imaged. As shown in
Figure 6, a marked increase in the EGFP signal was observed in
PC3-HRE-EGFP/HRE-ODD-luc/tdTomato cells treated with
CoCl2, whereas a only a background autofluorescence signal was
measured in normoxic cells. Similar levels of tdTomato signal
intensity were detected in both normoxic and CoCl2-treated cells
(Figure 6). A BLI signal was detected in CoCl2-treated but not in
normoxic PC3-HRE-GFP/HRE-ODD-luc/tdTomato cells
(Figure 6).
The Combination of Long-Lived EGFP and Short-Lived
ODD-Luciferase Allows Differentiation between Normoxic,
Hypoxic, and Reoxygenated PC3 Cells Using Optical Imaging
Taking advantage of the different stabilities of EGFP and
ODD-luc proteins, we next aimed to visualize normoxic, hypoxic,
and reoxygenated PC3-HRE-EGFP/HRE-ODD-luc/tdTomato cells
using optical imaging. As shown in the representative images in
Figure 7A and quantified intensities in Figure 7B, BLI activity was
detected in hypoxic PC3-HRE-EGFP/HRE-ODD-luc/tdTomato
cells but not in normoxic cells. After 4 hours of reoxygenation, the
BLI signal significantly dropped in these cells (Figure 7, A and B).
Representative EGFP images shown in Figure 7A and quantified
intensities in Figure 7B demonstrate the significant increase of signal
from hypoxic PC3-HRE-EGFP/HRE-ODD-luc/tdTomato cells
compared with normoxic cells. Consistent with its long-lived feature
and unlike the pattern from short-lived luciferase, the EGFP
fluorescence was not statistically different in hypoxic
PC3-HRE-EGFP/HRE-ODD-luc/tdTomato cells compared with
reoxygenated cells (Figure 7, A and B). However, a decrease in
tdTomato fluorescence was observed in hypoxic PC3-HRE-EGFP/
HRE-ODD-luc/tdTomato cells in comparison with normoxic and
reoxygenated cells (Figure 7, A and B). As shown in the representative
immunoblot in Figure 7C , HIF-1α was stabilized in
PC3-HRE-EGFP/HRE-ODD-luc/tdTomato cells after 48 hours at
1% O2 but not 4 hours after reoxygenation. EGFP protein levels
were found to increase after a 48-hour hypoxia treatment and were
sustained at 4 hours after reoxygenation (Figure 7C).
The "Timer" Imaging Method Based on the 5xHRE-EGFP
and 5xHRE-ODD-luc Constructs Allows the Dynamic
Visualization of HIF-1 Activation in PC3 Prostate Tumors
In proof-of-principle studies, PC3-HRE-EGFP/HRE-ODD-luc/
tdTomato cells were inoculated subcutaneously in a group of mice to
determine if differences in expression patterns of luciferase and
EGFP were detected. As shown in the representative images, tumors
where high intensity of BLI and EGFP regions colocalized were
Figure 4. Expression and stability of EGFP following different hypoxia-reoxygenation treatments in PC3-HRE-GFP/HRE-ODD-luc/tdTomato
cells. (A) Representative Western blot showing HIF-1α and EGFP protein expression in PC3-HRE-GFP/HRE-ODD-luc/tdTomato cells
incubated under normoxia, or under hypoxic conditions for 4, 8, 24, or 48 hours. For each hypoxic treatment, cells were immediately
collected for Western blot analysis (−) or reoxygenated for 4 hours (+). (B) Representative images of EGFP and tdTomato fluorescence of
PC3-HRE-GFP/HRE-ODD-luc/tdTomato cells following hypoxic treatments and reoxygenation for 4 hours.
876 HIF Optical Reporters with Different Half-Lives Danhier et al. Neoplasia Vol. 17, No. 12, 2015frequently observed (Figure 8A), which was confirmed in ex vivo
tissue slices (Figure 8B). We also observed patterns in some tumors
where high-intensity regions of BLI and EGFP did not colocalize,
which was confirmed in the ex vivo tissue slices and indicated
differences in the temporal evolution or resolution of HIF activity
and hypoxia.Figure 5. Luciferase activity of PC3-HRE-GFP/HRE-ODD-luc/tdTom
PC3-HRE-GFP/HRE-ODD-luc/tdTomato cells were submitted to hypox
luciferase assays (−) or reoxygenated for 4 hours (+) (n = 3). Data are
significant (ns), P N .05.We additionally performed in vivo and ex vivo imaging of the dual
HIF reporter system (EGFP/ODD-luciferase) in PC3 tumors
implanted in the prostate. Representative in vivo images are presented
in Figure 8C. Hypoxic tumor areas were not evident in the primary
tumor, but both EGFP and BLI were observed in a peritoneal
metastatic lesion.ato cells following different hypoxia-reoxygenation treatments.
ia treatments for 4, 8, 24, or 48 hours and immediately collected for
expressed as mean ± SEM. *P b .05; **P b .01; ***P b .001; not
Figure 6. In vitro fluorescence imaging and bioluminescence imaging of PC3-HRE-GFP/HRE-ODD-luc/tdTomato cells after CoCl2 addition.
EGFP (false color), tdTomato, and bioluminescence imaging of control or CoCl2-treated (200 μM for 24 hours) PC3-HRE-GFP/
HRE-ODD-luc/tdTomato cell pellets (3 × 106 cells/tube, n = 3). Exposure times were 1 second for EGFP, 0.1 second for tdTomato, and
1 minute for BLI. Data are expressed as mean ± SEM. *P b .05; **P b .01; ***P b .001; ns, P N .05.
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Here we have described an imaging strategy to determine the history of
HIF activation in prostate cancer cells. The use of a "timer" reporter
protein was first described in 2000 by Terskikh et al. [25]. The
fluorescence of this timer, named E5, changed from green to red in a
time-dependent manner after expression [25]. More recently, the
simultaneous use of two fluorescent proteins with different maturation
half-lives (fusion proteins or bicistronic expression) was described for
monitoring the temporal changes of the activity of a given reporter
[26–28]. Here, we have developed a timer strategy based on the
combination of two reporter genes, regulated by an HIF-dependent
promoter, with different degradation half-lives. Using optical imaging,
we demonstrated that the combination of a long-lived EGFP and a
short-lived luciferase fused to ODD allowed the identification of
normoxic (EGFP−/luc−), hypoxic (EGFP+/luc+), and reoxygenated
(EGFP+/luc−) prostate cancer cells. No cross talk between reporter
proteins was observed during the multiplex imaging of EGFP,
tdTomato, and bioluminescence in PC3 cells following a hypoxia
challenge. The EGFP degradation half-life values of 15 hours without
CHX treatment and approximately 83 minutes with CHX treatment
are comparable to previously published values [29], as are the
ODD-luciferase half-life values of approximately 34 minutes without
CHX treatment and approximately 11 minutes in CHX-treated cells
[11]. CHX treatment resulted in a steeper decline of luciferase activity
and EGFP protein compared with untreated cells undergoing
reoxygenation. This may be, in part, because the oxygen tensions
may have taken longer to equilibrate and recover to normoxic levels
during the reoxygenation process.
In the tumors, we observed colocalized regions of high BLI and high
EGFP, as well as regions that did not colocalize. Regions with high BLI
but low EGFPmay represent early hypoxia, regions with high BLI and
EGFP may represent long-term hypoxia, and regions with low BLI
and high EGFP may represent reoxygenated regions that werepreviously hypoxic. Because the reporters are being expressed
following HIF stabilization, it is also important to consider other
mechanisms that may induce HIF stabilization in vivo such as reactive
oxygen species that can be upregulated in tumors because of high
oxidative stress [10,30]. HIF stabilization due to oxidative stress may,
however, result in a more uniform expression of the reporters unlike
the distinct localized regions we observed in tumors in this study.
We previously observed that lymph node metastases arising from
PC3-HRE-EGFP orthotopic tumors emitted green fluorescence,
indicating the presence of hypoxic areas in metastases [20]. Here,
following tumor implantation in the orthotopic site that is permissive
to metastatic dissemination, we found no detectable hypoxia in the
primary but both EGFP and BLI in a peritoneal metastasis. Based on
the expression patterns of luciferase and EGFP, the "timer" strategy
described here could be used to determine whether metastatic
prostate cancer cells in the lymph nodes become hypoxic at the
metastatic site or were already hypoxic in the primary tumor.
Although serially imaging the luciferase reporter alone would detect
the presence of hypoxia, this would not provide a longer-term history
of whether hypoxia existed before reoxygenation in regions where
there is no luciferase activity. This information is important to
characterize the role of hypoxic environments in the primary tumor in
the metastatic process.
The fluorescence of the constitutive tdTomato protein, used for cell
tracking, was found to decrease at 1% O2 but remained constant after
incubation with CoCl2. This can be explained by the fact that an
oxidation step requiring O2 is needed in the maturation process of
fluorescent proteins to produce light. Differences in maturation rates or
oxygen requirements between fluorescent proteins may explain why
such a phenomenon was more pronounced with tdTomato compared
with EGFP [31,32]. In another study, pd2EGFP fluorescence decreased
but only at near-anoxic conditions (b0.06% O2) [33]. The authors
concluded that EGFPwas a suitable reporter gene for monitoring tumor
Figure 7. Optical imaging of long-lived EGFP and short-lived ODD-luciferase in normoxic, hypoxic, and reoxygenated PC3-HRE-GFP/
HRE-ODD-luc/tdTomato cells. (A) Representative optical images of PC3-HRE-GFP/HRE-ODD-luc/tdTomato pellets (3 × 106 cells/tube).
EGFP is displayed in red. Cells were exposed to normoxia, 48 hours 1% O2, or 48 hours 1% O2 followed by 4-hour reoxygenation. (B)
Quantification of EGFP, tdTomato, and BLI quantification of images acquired with the optical imaging scanner (n = 3 per group). (C)
Representative immunoblots of PC3-HRE-GFP/HRE-ODD-luc/tdTomato cell lysates showing HIF-1α and EGFP protein levels under
normoxia (N), 48 hours 1% O2, or 48 hours 1% O2 followed by 4-hour reoxygenation. Data are expressed as mean ± SEM. *P b .05;
**P b .01; ***P b .001; ns, P N .05.
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of light by luciferase proteins, Harada et al. [11] have observed that the
BLI signal coming from xenograft HeLa-HRE-ODD-luc tumors
implanted in the mouse leg increased after ligation, consistent with
the increased BLI signal of the HRE-ODD-luc construct in response to
hypoxia observed in our study. In a separate study, the BLI signal from
luciferase-positive 9L gliosarcoma cells was measured at various
percentages of O2 [34]. Only small differences were found in cells
exposed to 5% compared with 0.2% O2 [34], suggesting that ATP,
rather than oxygen levels, affected the luciferase activity in these cells
[34]. Sustained anoxia, on the other hand, will result in cell death and
the absence of both EGFP and BLI signal.
Tumor hypoxia is a poor prognosticator that is associated with
chemo- and radioresistance and recurrence [35,36]. As a result, HIF
targeting strategies are being evaluated in clinical trials (Clinical-Trials.gov identifier: NCT01111097). Briefly, chronic hypoxia
results from the limited diffusion of oxygen to tumor cells distant
from blood vessels [35], and acute hypoxia can result from vascular
collapse due to increased tumor interstitial pressure [35]. The
formation of hypoxia results in the upregulation of vascular
endothelial growth factor [37] that can lead to increased angiogenesis
and neovascularization and reoxygenation of hypoxic regions.
Reoxygenation also occurs during therapy when cell death provides
increased nutrients and oxygen to the remaining cells [38,39].
Cycling hypoxia due to variations of red blood cell flux in tumor
vessels has also been observed in tumors [40]. Endothelial cancer cells
submitted to cycling hypoxia had increased levels of HIF-1 induction
compared with cancer cells submitted to chronic hypoxia. This
phenomenon was associated with an increased survival of cancer cells
after radiotherapy in vivo [41].
Figure 8. Optical imaging patterns of two representative subcutaneous and orthotopic PC3-HRE-GFP/HRE-ODD-luc/tdTomato tumors
together with a metastatic lesion. (A) Representative in vivo images of EGFP and tdTomato fluorescence and bioluminescence of mice
with subcutaneous tumors. (B) Colocalization and mismatch between BLI and EGFP distributions in 2-mm–thick central tumor slice from
each tumor in (A) imaged ex vivo using a Xenogen IVIS Spectrum imager and fluorescence microscopy. The scale bar represents 2 mm.
(C) Representative in vivo images of EGFP and tdTomato fluorescence and bioluminescence of a mouse with a primary orthotopic tumor
(P) and a peritoneal metastatic lesion (M). No EGFP or BLI is detected in the primary tumor unlike the metastatic lesion that shows both
EGFP and BLI.
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880 HIF Optical Reporters with Different Half-Lives Danhier et al. Neoplasia Vol. 17, No. 12, 2015Cycling hypoxia was found to result from both fast fluctuations of
oxygenation (several cycles/hour) and slow fluctuations of oxygena-
tion (over many hours and days). It was hypothesized that
low-frequency variations in oxygen pressure in tumors could be due
to vascular remodeling following angiogenesis [42,43]. We observed
that a 24-hour incubation of PC3-HRE-EGFP/HRE-ODD-luc/
tdTomato cells at 1% O2 was required to detect EGFP using
fluorescence microscopy. Our results also showed that the luciferase
activity of PC3-HRE-EGFP/HRE-ODD-luc/tdTomato cells quickly
dropped after reoxygenation, whereas EGFP levels remained stable for
several hours. The dual EGFP/ODD-luciferase reporter system may
be used to detect reoxygenation processes due to angiogenesis after
long periods of hypoxia. Alternatively, the "timer" HIF imaging
strategy can detect rapid variations of O2 after sustained hypoxia. The
characterization of HIF inhibitors and radiosensitizing drugs that
alleviate tumor hypoxia is another promising field of application for
such an HIF imaging method [1,43–45].
One limitation of the reporter system developed here arises from
different sensing depths between EGFP and BLI. Unlike BLI,
fluorescence from EGFP is affected by tissue attenuation during
excitation and emission. As a result, in vivo variations in tissue thickness
will play a role in the EGFP intensities that are detected. Unlike the
in vivo data, because the ex vivo slices are of uniform thickness and only
2 mm thick, light attenuation may not be significant enough to pose a
problem when comparing EGFP and BLI intensity distribution.
Although the ex vivo slice data are ‘snapshots’ and do not allow
longitudinal studies, they still provide temporal insights into HIF and
hypoxia patterns in the tumor and in metastatic lesions. In addition, it
was not possible to perform single cell imaging using our current in vivo
optical imaging system, although fluorescence imaging of isolated cells
tagged with fluorescent reporter proteins has been reported in vivo using
intravital microscopy [46–48].
In conclusion, this novel "timer" imaging strategy of combining
the short-lived ODD-luciferase and the long-lived EGFP has the
potential to advance our understanding of temporal changes in
hypoxia and HIF in the primary tumor and during the metastatic
cascade, and for understanding therapy-based changes in tumor HIF
expression, especially for treatments that target the HIF pathway.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.neo.2015.11.007.
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